Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of GWZ003 granules in chronic kidney disease
CTR20261163Phase 2Active
- Sponsor
- Beijing Yingkairui Drug Research
- Start
- Sep 2026
- Countries
- 1
01
Overview
A Phase 2 trial of GWZ003 in chronic kidney disease (CKD), sponsored by Beijing Yingkairui Drug Research. Started Sep 2026; status: active.
02
Drugs
GWZ003
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20261163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261163.